Lightspeed Genomics

Santa Clara, United States Founded: 2006 • Age: 20 yrs Acquired By LGC Biosearch Technologies
Using proprietary optical imaging technology to develop DNA sequencing platform.

About Lightspeed Genomics

Lightspeed Genomics is a Healthcare company based in Santa Clara (United States) founded in 2006, and was acquired by LGC Biosearch Technologies in September 2013. Using proprietary optical imaging technology to develop DNA sequencing platform. It operates in the Healthcare and Technology sectors. Lightspeed Genomics has raised $5.08 million across 1 funding round from investors including LGC Biosearch Technologies. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics. Its competitors include PacBio, Omniome and Complete Genomics; 3 of its 3 listed competitors have raised funding.

Company details

Lightspeed Genomics was founded in 2006 in Santa Clara, United States, within the biotechnology sector. Optical imaging technology featuring light patterns with sub-pixel resolution is employed to illuminate samples and capture images via camera for analysis. This approach is applied to enable deep-submicron optical detection in high-density, high-throughput DNA sequencing. The company, previously known as Solametrix, has operated as a subsidiary of Biosearch Technologies since September 25, 2013.

Key Metrics

Funding Insights of Lightspeed Genomics

Lightspeed Genomics has successfully raised a total of $5.08M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.08 million completed in September 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $5.08M
  • Total Rounds 1
  • Last Round Series A β€” $5.08M
  • First Round $5.08M

    (Sep 2012)

All 1 funding rounds of Lightspeed Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2012$5.08MSeries A––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Lightspeed Genomics

Lightspeed Genomics has secured backing from 1 investor. Prominent investors backing the company include LGC Biosearch Technologies.

All
InvestorDescriptionFounded YearDomainLocation
Provider of genomic analysis tools, instrumentation and services
1993biosearchtech.comPetaluma, United States
Premium access

Investor details for Lightspeed Genomics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Lightspeed Genomics

1 people are tracked at Lightspeed Genomics (1 in leadership).

NameRoleGroup
Paul Sargeant
Chief Executive OfficerLeadership
Premium access

Complete people profiles for Lightspeed Genomics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Lightspeed Genomics

3 dated milestones of Lightspeed Genomics across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lightspeed Genomics is founded.
  2. Funding First funding round of $5.1M.
  3. Exit Acquired by LGC Biosearch Technologies.

Competitors of Lightspeed Genomics

Lightspeed Genomics has 3 listed competitors in our database, 3 of them funded. They include PacBio, Omniome and Complete Genomics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
pacb.com2004Menlo Park, United States$395M649
Instrument systems and software for single-molecule real-time sequencing are developed.
omniome.com2013San Diego, United States$160.23M164
Genome sequencing platform is provided for clinical diagnostics.
completegenomics.com2006San Jose, United States$124.99M70
DNA sequencing platform for human genome analysis is developed.
Premium access

Detailed competitors of Lightspeed Genomics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Lightspeed Genomics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Lightspeed Genomics

Lightspeed Genomics was founded in 2006 and raised its 1st funding round 6 years after it was founded.

Lightspeed Genomics is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.

Lightspeed Genomics is a funded company, having raised a total of $5.08M across 1 funding round to date. The company's 1st funding round was a Series A of $5.08M, raised on Sep 2012.

Lightspeed Genomics was founded in 2006 in Santa Clara, United States, within the biotechnology sector. Optical imaging technology featuring light patterns with sub-pixel resolution is employed to illuminate samples and capture images via camera for analysis. This approach is applied to enable deep-submicron optical detection in high-density, high-throughput DNA sequencing. The company, previously known as Solametrix, has operated as a subsidiary of Biosearch Technologies since September 25, 2013.

Lightspeed Genomics's top competitors include PacBio, Complete Genomics and Omniome.

Lightspeed Genomics has 1 investor. Key investors include LGC Biosearch Technologies.

Yes. Lightspeed Genomics was acquired by LGC Biosearch Technologies in September 2013.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available